Psych MEQs / SAQs · Intellectual disability — neurodevelopmental
Foetal alcohol spectrum disorder — diagnosis, neurobehaviour and management (MEQ)
FRANZCP-style MEQ on FASD diagnostic systems, neurobehavioural profile, differentials, secondary disability prevention, comorbidity pharmacotherapy principles, and prevention counselling.
On this page & tools
Target exams
Model answer
Reveal model answer
(i) Definition and diagnostic framework. FASD is the umbrella for lifelong effects of prenatal alcohol exposure (PAE) on brain, behaviour, growth and (when present) face. Apply a named system: e.g. Hoyme 2016 (combinations of confirmed PAE, growth deficiency, sentinel facial features — short palpebral fissures, smooth philtrum, thin upper vermilion — and neurobehavioural impairment) or Cook 2016 Canadian categories of FASD with/without sentinel facial features requiring severe brain dysfunction domains, or Astley 4-digit ranks for growth, face, CNS and alcohol. This child has documented PAE, suggestive facial features and clear CNS/neurobehavioural impairment → multidisciplinary FASD diagnostic pathway, not ADHD label alone.[1][2]
(ii) Neurobehaviour and differentials. Expect executive dysfunction, attention dysregulation, learning/memory weaknesses and adaptive skills lagging IQ expectations.[5] ADHD alone: social-adaptive and PAE/dysmorphology history tip to dual FASD±ADHD framing. ASD: may co-occur; reciprocal social pattern and RRBs vs PAE adaptive profile. Trauma/kinship adversity: co-traveller — formulate both; do not erase teratogenic effects.[4][6]
(iii) Non-drug care and secondary disabilities. Environmental scaffolding (visual schedules, reduced cognitive load, consistent carers), school accommodations, carer coaching, disability supports, hearing/vision screens. Streissguth: high secondary disability rates (school disruption, legal trouble, confinement, substance use, inappropriate sexual behaviour); earlier diagnosis and stable nurturing care improve odds of escaping adverse outcomes.[3][4]
(iv) Pharmacotherapy principles. No disease-modifying drug for core FASD. Treat comorbidities: ADHD pathway (behavioural ± stimulant/non-stimulant, monitor growth/sleep/appetite/mood); cautious treatment of anxiety/mood/sleep; antipsychotics only for severe risk behaviour after functional analysis, lowest effective dose, metabolic monitoring, time-limited goals.[4][6]
(v) Prevention counselling. No known safe amount of alcohol in pregnancy; support alcohol-free pregnancy planning; treat alcohol use disorder and offer contraception to people of reproductive potential in the network; non-judgemental tone to enable disclosure and care.[4]
Common errors
- Excluding FASD because IQ is not extremely low.
- Requiring the full face triad for any FASD diagnosis.
- Claiming a specific tablet cures FASD.
- Mother-blame without taking a careful PAE history.
- Omitting secondary disability and multiagency plan. [1][3]
Examiner notes
Full marks need a named diagnostic system, neurobehavioural profile with discriminators, Streissguth-level secondary disability framing, explicit “no core disease-modifying drug,” and prevention messaging. Vague “refer to paeds and start risperidone” fails. [1][3][6]
References
- [1]Hoyme HE, Kalberg WO, Elliott AJ, et al. Updated Clinical Guidelines for Diagnosing Fetal Alcohol Spectrum Disorders Pediatrics, 2016.PMID 27464676
- [2]Cook JL, Green CR, Lilley CM, et al. Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan CMAJ, 2016.PMID 26668194
- [3]Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'Malley K, Young JK Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects J Dev Behav Pediatr, 2004.PMID 15308923
- [4]Williams JF, Smith VC; Committee on Substance Abuse Fetal Alcohol Spectrum Disorders Pediatrics, 2015.PMID 26482673
- [5]Mattson SN, Bernes GA, Doyle LR Fetal Alcohol Spectrum Disorders: A Review of the Neurobehavioral Deficits Associated With Prenatal Alcohol Exposure Alcohol Clin Exp Res, 2019.PMID 30964197
- [6]Wozniak JR, Riley EP, Charness ME Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder Lancet Neurol, 2019.PMID 31160204